Atyr Pharma Inc (ATYR)

$0.50 0.00 (-0.30%)
Market Cap 49.34M
Revenue (ttm) 190,000.00
Net Income (ttm) -74.12M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -39,010.53%
Debt to Equity Ratio 0.00
Volume 522,700
Avg Vol 1,464,332
Day's Range N/A - N/A
Shares Out 98.09M
Stochastic %K 2%
Beta 0.54
Analysts Sell
Price Target $2.75

Company Profile

aTyr Pharma, Inc., a clinical stage biotechnology company, engages in the discovery and development of product candidates that translate tRNA synthetase biology into new therapies for fibrosis and inflammation in the United States. Its lead therapeutic candidate efzofitimod, a selective modulator of NRP2 that is in Phase 3 clinical trial for the treatment of pulmonary sarcoidosis; Phase 2 clinical trial to treat Sarcoidosis and systemic sclerosis- interstitial lung disease (ILDs); and treatment...

Industry: Biotechnology
Sector: Healthcare
Phone: 858 731 8389
Fax: 858 731 8394
Address:
10240 Sorrento Valley Road, Suite 300, San Diego, United States
Brandonswest
Brandonswest Aug. 21 at 7:12 PM
$ATYR bought in. 10k at .52. Hoping for the best.
1 · Reply
bigron8671
bigron8671 Aug. 21 at 10:21 AM
$ATYR Buying a few more at this price before the P3 run.
1 · Reply
Spiceman63
Spiceman63 Aug. 20 at 5:51 PM
$ATYR Some interesting comments in the article. https://fbroker.kz/en/news/51511-fb-atyr-pharma-shares-have-over-500-upside-as-the-company-prepares-a-new-phase-iii-en-2
0 · Reply
tedypa
tedypa Aug. 20 at 4:09 AM
$ATYR I'm waiting for FDA response and First dose announcement!
1 · Reply
TOM_10
TOM_10 Aug. 19 at 6:39 PM
$ATYR added
1 · Reply
saneguy
saneguy Aug. 19 at 4:13 PM
$ATYR what happened to the last earnings ?
1 · Reply
Gravitationalsingularity
Gravitationalsingularity Aug. 17 at 2:37 PM
$ATYR Possible cup and handle forming on the daily.
0 · Reply
bigron8671
bigron8671 Aug. 14 at 5:51 PM
$ATYR nice accumulation this week !
1 · Reply
HansDampf1
HansDampf1 Aug. 13 at 11:27 PM
$ATYR The institutional Iínvestors have decreased their positions: Remarkable Institutional Ownership 39.72% Increased Positions 48 6,568,609 Decreased Positions 59 27,276,020 nasdaq.com
1 · Reply
stefano62
stefano62 Aug. 13 at 6:39 PM
$ATYR why this Spike without any news?
2 · Reply
Latest News on ATYR
Ethos to Present at the Goldman Sachs Communacopia + Technology Conference

Aug 19, 2026, 4:05 PM EDT - 2 days ago

Ethos to Present at the Goldman Sachs Communacopia + Technology Conference

LIFE

Ethos Signs Erin Andrews as Its Next Sports Partner in Growing Campaign to Make Life Insurance Accessible for Every Family

Aug 13, 2026, 9:05 AM EDT - 8 days ago

Ethos Signs Erin Andrews as Its Next Sports Partner in Growing Campaign to Make Life Insurance Accessible for Every Family

LIFE

aTyr Pharma reports Q2 EPS (11c), consensus (13c)

2026-08-07T20:10:20.000Z - 14 days ago

aTyr Pharma reports Q2 EPS (11c), consensus (13c)

aTyr Pharma announces restructuring, will lay off roughly 60% of workforce

2026-08-07T20:05:31.000Z - 14 days ago

aTyr Pharma announces restructuring, will lay off roughly 60% of workforce

aTyr Pharma Announces Second Quarter 2026 Results, Program Prioritization and Corporate Restructuring to Support Efzofitimod Program in ILD

Aug 7, 2026, 4:01 PM EDT - 14 days ago

aTyr Pharma Announces Second Quarter 2026 Results, Program Prioritization and Corporate Restructuring to Support Efzofitimod Program in ILD

aTyr Pharma Quarterly report: Q2 2026

Aug 7, 2026, 7:00 AM EDT - 14 days ago

aTyr Pharma Quarterly report: Q2 2026

aTyr Pharma Earnings release: Q2 2026

Aug 7, 2026, 7:00 AM EDT - 14 days ago

aTyr Pharma Earnings release: Q2 2026

Ethos Reports Second Quarter Fiscal Year 2026 Financial Results

Aug 3, 2026, 4:05 PM EDT - 18 days ago

Ethos Reports Second Quarter Fiscal Year 2026 Financial Results

LIFE

Ethos and North American Expand Their Indexed Universal Life Product Offering to include Children

Jul 21, 2026, 9:07 AM EDT - 4 weeks ago

Ethos and North American Expand Their Indexed Universal Life Product Offering to include Children

LIFE

aTyr Pharma to Present Subgroup Analysis of Phase 3 EFZO-FIT™ Study of Efzofitimod in Pulmonary Sarcoidosis at WASOG 2026

Jul 15, 2026, 8:00 AM EDT - 5 weeks ago

aTyr Pharma to Present Subgroup Analysis of Phase 3 EFZO-FIT™ Study of Efzofitimod in Pulmonary Sarcoidosis at WASOG 2026

Ethos to Announce Second Quarter 2026 Financial Results on August 3, 2026

Jul 2, 2026, 4:35 PM EDT - 7 weeks ago

Ethos to Announce Second Quarter 2026 Financial Results on August 3, 2026

LIFE

aTyr Pharma Transcript: Life Sciences Virtual Investor Forum

Jun 25, 2026, 3:30 PM EDT - 2 months ago

aTyr Pharma Transcript: Life Sciences Virtual Investor Forum

aTyr Pharma Transcript: Jefferies Global Healthcare Conference 2026

Jun 4, 2026, 3:45 PM EDT - 2 months ago

aTyr Pharma Transcript: Jefferies Global Healthcare Conference 2026

Forget the SpaceX IPO. These 2 New Stocks Stand Out Right Now.

May 26, 2026, 3:08 PM EDT - 3 months ago

Forget the SpaceX IPO. These 2 New Stocks Stand Out Right Now.

LIFE PTRN

Ethos Partners with Baseball Legend David Ortiz to Champion Life Insurance as a Family Financial Essential

May 21, 2026, 9:07 AM EDT - 3 months ago

Ethos Partners with Baseball Legend David Ortiz to Champion Life Insurance as a Family Financial Essential

LIFE

aTyr Pharma upgraded to Buy from Hold at Freedom Broker

2026-05-20T13:00:12.000Z - 3 months ago

aTyr Pharma upgraded to Buy from Hold at Freedom Broker

Ethos to Present at Upcoming Investor Conferences

May 15, 2026, 4:30 PM EDT - 3 months ago

Ethos to Present at Upcoming Investor Conferences

LIFE

aTyr Pharma reports Q1 EPS (11c), consensus (15c)

2026-05-15T15:42:31.000Z - 3 months ago

aTyr Pharma reports Q1 EPS (11c), consensus (15c)

aTyr Pharma Announces First Quarter 2026 Results and Provides Corporate Update

May 15, 2026, 8:00 AM EDT - 3 months ago

aTyr Pharma Announces First Quarter 2026 Results and Provides Corporate Update

aTyr Pharma Quarterly report: Q1 2026

May 15, 2026, 7:00 AM EDT - 3 months ago

aTyr Pharma Quarterly report: Q1 2026

aTyr Pharma Earnings release: Q1 2026

May 15, 2026, 7:00 AM EDT - 3 months ago

aTyr Pharma Earnings release: Q1 2026

Ethos Announces Early Lock-Up Release

May 13, 2026, 4:35 PM EDT - 3 months ago

Ethos Announces Early Lock-Up Release

LIFE

aTyr Pharma to Participate in Upcoming Investor Conferences

May 13, 2026, 4:01 PM EDT - 3 months ago

aTyr Pharma to Participate in Upcoming Investor Conferences

aTyr Pharma provides regulatory update on efzofitimod following Type C meeting

2026-05-11T23:05:03.000Z - 3 months ago

aTyr Pharma provides regulatory update on efzofitimod following Type C meeting

aTyr Pharma Transcript: Study update

May 11, 2026, 4:30 PM EDT - 3 months ago

aTyr Pharma Transcript: Study update

aTyr Pharma Press release: Study update

May 11, 2026, 4:30 PM EDT - 3 months ago

aTyr Pharma Press release: Study update

aTyr Pharma Slides: Study update

May 11, 2026, 4:30 PM EDT - 3 months ago

aTyr Pharma Slides: Study update

aTyr Pharma Provides Regulatory and Clinical Update for Efzofitimod in Pulmonary Sarcoidosis Following FDA Type C Meeting

May 11, 2026, 4:01 PM EDT - 3 months ago

aTyr Pharma Provides Regulatory and Clinical Update for Efzofitimod in Pulmonary Sarcoidosis Following FDA Type C Meeting

Ethos Reports First Quarter Fiscal Year 2026 Financial Results

May 6, 2026, 4:05 PM EDT - 3 months ago

Ethos Reports First Quarter Fiscal Year 2026 Financial Results

LIFE

Ethos Launches ChatGPT App To Bring Instant Life Insurance Estimates to 900 Million Users

May 5, 2026, 9:07 AM EDT - 3 months ago

Ethos Launches ChatGPT App To Bring Instant Life Insurance Estimates to 900 Million Users

LIFE

Ethos Collaborates with Liberty Mutual to Deliver a Modern, Digital-First Life Insurance Experience

Apr 23, 2026, 9:07 AM EDT - 4 months ago

Ethos Collaborates with Liberty Mutual to Deliver a Modern, Digital-First Life Insurance Experience

LIFE

Ethos to Announce First Quarter 2026 Financial Results on May 6, 2026

Apr 2, 2026, 4:05 PM EDT - 5 months ago

Ethos to Announce First Quarter 2026 Financial Results on May 6, 2026

LIFE

aTyr Pharma Proxy statement: Proxy filing

Mar 26, 2026, 8:00 AM EDT - 5 months ago

aTyr Pharma Proxy statement: Proxy filing

aTyr Pharma Proxy statement: Proxy filing

Mar 26, 2026, 8:00 AM EDT - 5 months ago

aTyr Pharma Proxy statement: Proxy filing

Ethos and Banner Life Expand Offering to Bring Final Expense Coverage to More Families

Mar 24, 2026, 4:05 PM EDT - 5 months ago

Ethos and Banner Life Expand Offering to Bring Final Expense Coverage to More Families

LIFE

aTyr Pharma Proxy statement: Proxy Filing

Mar 12, 2026, 8:00 AM EDT - 5 months ago

aTyr Pharma Proxy statement: Proxy Filing

aTyr Pharma Transcript: Leerink Global Healthcare Conference 2026

Mar 11, 2026, 8:00 AM EDT - 5 months ago

aTyr Pharma Transcript: Leerink Global Healthcare Conference 2026

aTyr Pharma reports Q4 EPS (14c), consensus (17c)

2026-03-05T21:05:56.000Z - 6 months ago

aTyr Pharma reports Q4 EPS (14c), consensus (17c)

aTyr Pharma Announces Fourth Quarter and Full Year 2025 Results and Provides Corporate Update

Mar 5, 2026, 4:01 PM EST - 6 months ago

aTyr Pharma Announces Fourth Quarter and Full Year 2025 Results and Provides Corporate Update

aTyr Pharma Annual report: Q4 2025

Mar 5, 2026, 3:00 PM EST - 6 months ago

aTyr Pharma Annual report: Q4 2025

aTyr Pharma Earnings release: Q4 2025

Mar 5, 2026, 3:00 PM EST - 6 months ago

aTyr Pharma Earnings release: Q4 2025

Ethos to Participate in The Citizens Technology Conference

Feb 26, 2026, 4:06 PM EST - 6 months ago

Ethos to Participate in The Citizens Technology Conference

LIFE

Ethos Reports Fourth Quarter and Fiscal Year 2025 Financial Results

Feb 25, 2026, 4:05 PM EST - 6 months ago

Ethos Reports Fourth Quarter and Fiscal Year 2025 Financial Results

LIFE

aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Feb 20, 2026, 4:01 PM EST - 6 months ago

aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

aTyr Pharma to Present at the Leerink Partners Global Healthcare Conference

Feb 18, 2026, 8:00 AM EST - 6 months ago

aTyr Pharma to Present at the Leerink Partners Global Healthcare Conference

Ethos to Announce Fourth Quarter 2025 Financial Results on February 25, 2026

Feb 5, 2026, 4:05 PM EST - 7 months ago

Ethos to Announce Fourth Quarter 2025 Financial Results on February 25, 2026

LIFE

The IPO Market Faces a Busy Week. These Stocks Are Making Their Debuts.

Feb 3, 2026, 2:46 PM EST - 7 months ago

The IPO Market Faces a Busy Week. These Stocks Are Making Their Debuts.

FPS LFTO YSS

aTyr Pharma announces U.S. FDA accepted meeting request for efzofitimod

2026-02-03T13:10:35.000Z - 7 months ago

aTyr Pharma announces U.S. FDA accepted meeting request for efzofitimod

aTyr Pharma Announces Scheduling of FDA Type C Meeting to Discuss Efzofitimod Program in Pulmonary Sarcoidosis

Feb 3, 2026, 8:00 AM EST - 7 months ago

aTyr Pharma Announces Scheduling of FDA Type C Meeting to Discuss Efzofitimod Program in Pulmonary Sarcoidosis

Insurance platform Ethos Technologies valued at $1.2 billion in Nasdaq debut

Jan 29, 2026, 12:30 PM EST - 7 months ago

Insurance platform Ethos Technologies valued at $1.2 billion in Nasdaq debut

Ethos Announces Pricing of Initial Public Offering

Jan 28, 2026, 10:38 PM EST - 7 months ago

Ethos Announces Pricing of Initial Public Offering

Ethos Technologies prices US IPO at $19/share, Bloomberg News reports

Jan 28, 2026, 9:05 PM EST - 7 months ago

Ethos Technologies prices US IPO at $19/share, Bloomberg News reports

Ethos and North American Collaborate to Offer Accumulation Indexed Universal Life Product

Jan 7, 2026, 8:01 AM EST - 8 months ago

Ethos and North American Collaborate to Offer Accumulation Indexed Universal Life Product

Ethos and Aflac Partner to Bring Supplemental Health Product Suite to Independent Distribution

Dec 18, 2025, 8:01 AM EST - 8 months ago

Ethos and Aflac Partner to Bring Supplemental Health Product Suite to Independent Distribution

Johnson Fistel Investigates Claims on Behalf of aTyr Pharma, Inc. (ATYR) Shareholders

Dec 15, 2025, 2:45 PM EST - 8 months ago

Johnson Fistel Investigates Claims on Behalf of aTyr Pharma, Inc. (ATYR) Shareholders

aTyr Pharma, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - ATYR

Dec 8, 2025, 3:25 AM EST - 9 months ago

aTyr Pharma, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - ATYR

aTyr Pharma Transcript: Piper Sandler 37th Annual Healthcare Conference

Dec 2, 2025, 1:00 PM EST - 9 months ago

aTyr Pharma Transcript: Piper Sandler 37th Annual Healthcare Conference

aTyr Pharma Faces Class Action after Clinical Trial Failure Raises Investor Concerns

2025-11-25T15:09:57.000Z - 9 months ago

aTyr Pharma Faces Class Action after Clinical Trial Failure Raises Investor Concerns

aTyr Pharma reports Q3 EPS (26c), consensus (18c)

2025-11-06T21:26:32.000Z - 10 months ago

aTyr Pharma reports Q3 EPS (26c), consensus (18c)

aTyr Pharma Earnings release: Q3 2025

Nov 6, 2025, 4:00 PM EST - 10 months ago

aTyr Pharma Earnings release: Q3 2025

aTyr Pharma Quarterly report: Q3 2025

Nov 6, 2025, 4:00 PM EST - 10 months ago

aTyr Pharma Quarterly report: Q3 2025

aTyr Pharma reports clinical benefit for efzofitimod across multiple diseases

2025-09-30T10:20:48.000Z - 11 months ago

aTyr Pharma reports clinical benefit for efzofitimod across multiple diseases

Piper Sandler healthcare analysts hold an analyst/industry conference call

2025-09-29T20:40:08.000Z - 11 months ago

Piper Sandler healthcare analysts hold an analyst/industry conference call

aTyr Pharma downgraded to Sector Perform from Outperform at RBC Capital

2025-09-15T20:30:25.000Z - 1 year ago

aTyr Pharma downgraded to Sector Perform from Outperform at RBC Capital

Brandonswest
Brandonswest Aug. 21 at 7:12 PM
$ATYR bought in. 10k at .52. Hoping for the best.
1 · Reply
bigron8671
bigron8671 Aug. 21 at 10:21 AM
$ATYR Buying a few more at this price before the P3 run.
1 · Reply
Spiceman63
Spiceman63 Aug. 20 at 5:51 PM
$ATYR Some interesting comments in the article. https://fbroker.kz/en/news/51511-fb-atyr-pharma-shares-have-over-500-upside-as-the-company-prepares-a-new-phase-iii-en-2
0 · Reply
tedypa
tedypa Aug. 20 at 4:09 AM
$ATYR I'm waiting for FDA response and First dose announcement!
1 · Reply
TOM_10
TOM_10 Aug. 19 at 6:39 PM
$ATYR added
1 · Reply
saneguy
saneguy Aug. 19 at 4:13 PM
$ATYR what happened to the last earnings ?
1 · Reply
Gravitationalsingularity
Gravitationalsingularity Aug. 17 at 2:37 PM
$ATYR Possible cup and handle forming on the daily.
0 · Reply
bigron8671
bigron8671 Aug. 14 at 5:51 PM
$ATYR nice accumulation this week !
1 · Reply
HansDampf1
HansDampf1 Aug. 13 at 11:27 PM
$ATYR The institutional Iínvestors have decreased their positions: Remarkable Institutional Ownership 39.72% Increased Positions 48 6,568,609 Decreased Positions 59 27,276,020 nasdaq.com
1 · Reply
stefano62
stefano62 Aug. 13 at 6:39 PM
$ATYR why this Spike without any news?
2 · Reply
CapitalMonk
CapitalMonk Aug. 13 at 3:42 PM
$ATYR Price: $0.57 (+4.87%) Trend: Bearish Market Bias (7D): Bearish Bias 📉 Expected Range: ±5.52% RSI: 76.6 | Momentum: Strong Momentum Volume: -45.8% vs avg Volatility: 3.20% Support: $0.46 | Resistance: $0.58 Data and analytics sourced from Thescanner educational research https://www.thescanner.ai
0 · Reply
bigron8671
bigron8671 Aug. 12 at 12:51 PM
$ATYR after buying 13m shares back in the last month and a half , shorts now added 1.5m.
0 · Reply
Indialli1309
Indialli1309 Aug. 12 at 7:43 AM
$ATYR https://www.moomoo.com/news/post/74490072/wells-fargo-maintains-atyr-pharma-atyrus-with-hold-rating-maintains?level=1&data_ticket=1785995132554816 momentum is changing!
0 · Reply
__Godzilla__
__Godzilla__ Aug. 10 at 1:32 PM
$ATYR Some good news from the aTyr earnings report on Friday. Based on its current cash and new operating expense forecast and plans, management believes cash is sufficient to fund the Company’s current operations into late 2028. This is not investment advice nor a recommendation to buy.
0 · Reply
Indialli1309
Indialli1309 Aug. 10 at 11:57 AM
$ATYR I am proud to be bullish on this stock!
0 · Reply
Grass_fire
Grass_fire Aug. 8 at 7:27 AM
$ATYR waiting for $1
0 · Reply
Spiceman63
Spiceman63 Aug. 7 at 8:31 PM
$ATYR Company expects FDA feedback on Phase 3 efzofitimod protocol by end-August 2026.
0 · Reply
Indialli1309
Indialli1309 Aug. 7 at 8:15 PM
$ATYR https://investors.atyrpharma.com/news-releases/news-release-details/atyr-pharma-announces-second-quarter-2026-results-program feedback from FDA in end of August.
0 · Reply
Kid70
Kid70 Aug. 7 at 2:08 PM
$ATYR 13 g filed. 2. 464. 141 by fidelity
0 · Reply
rio245
rio245 Aug. 6 at 4:11 PM
$ATYR when is earnings call? I thought it was this morning.
1 · Reply
Benben1515
Benben1515 Aug. 5 at 1:38 PM
$ATYR also anything that can fluctuate the prices?
0 · Reply
Benben1515
Benben1515 Aug. 5 at 1:37 PM
$ATYR any news to be looking forward to??
0 · Reply